KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2025)

Historic Gross Profit for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $30.7 million.

  • Ginkgo Bioworks Holdings' Gross Profit fell 6121.88% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.5 million, marking a year-over-year decrease of 2148.17%. This contributed to the annual value of $188.5 million for FY2024, which is 802.07% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Gross Profit of $30.7 million as of Q3 2025, which was down 6121.88% from $40.2 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Gross Profit ranged from a high of $79.1 million in Q3 2024 and a low of -$126.1 million during Q1 2023
  • Moreover, its 5-year median value for Gross Profit was -$13.6 million (2021), whereas its average is -$13.9 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Gross Profit crashed by 71242.73% in 2022, and later skyrocketed by 16014.21% in 2023.
  • Ginkgo Bioworks Holdings' Gross Profit (Quarter) stood at -$13.6 million in 2021, then plummeted by 712.43% to -$110.4 million in 2022, then soared by 132.28% to $35.6 million in 2023, then grew by 1.88% to $36.3 million in 2024, then fell by 15.52% to $30.7 million in 2025.
  • Its last three reported values are $30.7 million in Q3 2025, $40.2 million for Q2 2025, and $40.4 million during Q1 2025.